Target intelligence / Profile preview

Novel antisense transcript to CTXN1 and TIMM44 (ENSG00000269139)

Target
ENSG00000269139
Molecular classification
Other (long non-coding RNA, antisense RNA)
01

Overview

This is a novel, uncharacterized transcript annotated as antisense to the protein-coding genes CTXN1 and TIMM44, based on its genomic position on chromosome 19. It appears in genome annotation databases such as Ensembl and may represent a long non-coding RNA or other regulatory element. No experimental literature describes a biological function, disease association, or utility as a therapeutic target for ENSG00000269139. It does not encode a known protein, nor is it classified as a receptor, enzyme, transporter, transcription factor, or other recognized therapeutic target class. The lack of characterization and absence from direct disease or drug interaction studies indicate that it is not considered a canonical target. Any functional or clinical implication remains unstudied or unknown[2][4].

Other names
Novel transcript antisense to CTXN1 and TIMM44ENSG00000269139

Beyond the preview

Go deeper on Novel antisense transcript to CTXN1 and TIMM44 (ENSG00000269139).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel antisense transcript to CTXN1 and TIMM44 (ENSG00000269139).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call